Overview

The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer

Status:
Completed
Trial end date:
2021-06-30
Target enrollment:
Participant gender:
Summary
This is a prospective cohort study on the effect of Andrographis Paniculata (AP) on palliative management of patients with advanced or metastatic esophageal cancer. A total of 30 patients with locally advanced or metastatic squamous esophageal cancer will be recruited for the trial.
Phase:
Phase 3
Details
Lead Sponsor:
Chinese University of Hong Kong
Treatments:
Andrographolide